.png)
Lyme Economy Dashboard
Lyme Economy Dashboard focused on the financial impact of Lyme disease globally. The USA bears the highest economic burden with costs between $50-$100 billion annually, followed by significant impacts on productivity and tourism industries. Europe is highlighted with an estimated €500 million to €1 billion in annual healthcare costs, while individual productivity impacts in Canada and Europe are noted at $500 million and €73 million, respectively. The dashboard visualizes research focus distribution, a network of investors, and industry leadership profiles.
$50 - $100 billion
Total Annual Economic Cost(USA)
$2.5 billion
Economic Impact of Lost Productivity
$500M
Impact on USA Tourism Industry (per year)
35-50%
Economic Impact of Chronic Lyme Disease
Enhanced SWOT Comparison
Summary:
-
Key Metrics: The table evaluates a range of clinics across countries like the USA, India, and Canada, highlighting diagnostic, infrastructure, and financial scores. Clinics are assessed across multiple service categories such as post-COVID care, therapeutic targeting, and collaborative science.
-
Service Insights: The service scores include measures like diagnostic equipment, team expertise, infrastructure, and COVID-related services, showing variation across clinics globally.
Lyme Economy Overview
Summary:
-
Key Metrics: The Lyme Economy dashboard highlights the economic impact of Lyme disease, with costs ranging between $712 million and $1.3 billion annually in the USA.
-
Regional Insights: The USA bears the highest economic burden, followed by Canada and the Netherlands, with Europe and the UK showing relatively lower impacts.
.png)
